Insights

Evan and Tom look at the most commonly asked about assets when it comes to investing.

Top financial adviser Sally Huynh joins James Kirby in this week's episode of The Money Café for a discussion on the key issues and investment trends emerging from COVID including gold's spectacular rally, early super withdrawals and the state of industry funds as airports and toll roads struggle.

Alex Gluyas speaks with the CEO of REA Group, Owen Wilson, about the year that has been in Australia's property market, from the Hayne Royal Commission's impact, the signs of recovery earlier this year and then the onset of COVID, and his thoughts on why the property market might escape in better condition than first thought.

Scott Francis explains why current market conditions have given investors who feel they have been caught short of cash, an opportunity to take an income planning approach to their portfolio construction.

This week on Talking Finance, Alex Gluyas is joined by Professor of Infectious Diseases at ANU’s Medical School, Professor Peter Collignon, for a global discussion on all things COVID, including how safe Russia's rushed vaccine is, Sweden's herd immunity strategy and why Australia needs to learn how to live with the virus, while Portfolio Manager at Tribeca Investment Partners, Jun Bei Liu, gives her take on earnings season so far and what's driven the Nasdaq and S&P 500 to record highs. EY Oceania Chief Economist, Jo Masters, explains why Australia's economic fundamentals place it in better shape than most nations to get through the current downturn and Political Editor at The New Daily, Josh Butler, shares his thoughts on Victoria's hotel quarantine inquiry and China’s latest curveball to Australia’s wine industry.

Steve Sammartino takes an in-depth look at 5G including the evolution of telecommunications, why it's time to believe the hype and what prospects it holds for investors.

Following its recent listing on the ASX, Alex Gluyas speaks with the founder and CEO of 4DMedical, Andreas Fouras, to discuss the company's lung imaging technology, its usefulness in detecting and managing acute respiratory distress syndrome (ARDS) in COVID patients and the process of commercialising in the US and beyond.

Alex Gluyas catches up with the CEO of Ava Risk Group, Rob Broomfield, to discuss his transition to being the group's CEO, how the company has navigated through COVID and its most recent quarterly update which saw its share price spike.

Not everyone can directly ask one of Australia's most trusted finance brains in Paul Clitheroe for advice. I consider it one of the perks of the job.

Core-Satellite investing allows you to blend strategies, it allows for you to make your own investment decisions whilst lowering or increasing your exposure to risk and/or volatility.

Australia's open banking regime has kicked off, and it could pave the way to scoring a better deal.

InvestSMART Capped Fee Portfolio review: 'The Monthly Musing' Riding the second wave

In this week's Q&A, Eureka Report's SMSF Coach and Prime Financial Group's Managing Director of SMSF, Olivia Long, answers a number of subscriber questions relating to self-managed super funds.

Robert Gottliebsen takes an in-depth look at Transurban and the Commonwealth Bank of Australia's results and the insight it gives into the state of the economy while looking to the US where turmoil in Congress has seen a rise in bond yields.

With the onset of COVID, Zoom's daily active participants soared from 10 million to 300 million. Alex Gluyas catches up with the video conferencing giant's head of Australia and Asia Pacific, Michael Chetner, to discuss how it was forced to pivot from focusing on its main enterprise market to keeping society connected, the privacy and security issues it's faced and where Zoom fits into life post-COVID.

Following its recent listing on the ASX, Alex Gluyas speaks with the CEO of Aroa Biosurgery, Brian Ward, to discuss the company's IPO, its medical products used for soft tissue regeneration, and the expansion of its commercial operations in the US and beyond.